Iris Roth Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Iris Roth is Chief Operating Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 52,500 shares of ZNTL, which is worth approximately $169,575. The most recent transaction as insider was on Mar 01, 2023, when has been sold 52,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.5K
0% 3M change
0% 12M change
Total Value Held $169,575

Iris Roth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2023
BUY
Grant, award, or other acquisition
-
52,500 Added 50.0%
52,500 Common Stock
IR

Iris Roth

Chief Operating Officer
New York, NY

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL